BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31616413)

  • 1. Pharmacological Blockade of Spinal CXCL3/CXCR2 Signaling by NVP CXCR2 20, a Selective CXCR2 Antagonist, Reduces Neuropathic Pain Following Peripheral Nerve Injury.
    Piotrowska A; Rojewska E; Pawlik K; Kreiner G; Ciechanowska A; Makuch W; Nalepa I; Mika J
    Front Immunol; 2019; 10():2198. PubMed ID: 31616413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia.
    Kwiatkowski K; Popiolek-Barczyk K; Piotrowska A; Rojewska E; Ciapała K; Makuch W; Mika J
    Cytokine; 2019 Jul; 119():202-213. PubMed ID: 31003094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Effects of Chemokine Receptors CXCR2 and CXCR3 Pharmacological Modulation in Neuropathic Pain Model-
    Piotrowska A; Ciapała K; Pawlik K; Kwiatkowski K; Rojewska E; Mika J
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of keratinocyte-derived chemokine (KC) on hyperalgesia caused by peripheral nerve injury in mice.
    Manjavachi MN; Costa R; Quintão NL; Calixto JB
    Neuropharmacology; 2014 Apr; 79():17-27. PubMed ID: 24184386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation of CXCL1 in the glial cells during neuropathic pain.
    Moraes TR; Elisei LS; Malta IH; Galdino G
    Eur J Pharmacol; 2020 May; 875():173039. PubMed ID: 32119843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal CXCL5 contributes to nerve injury-induced neuropathic pain via modulating GSK-3β phosphorylation and activity in rats.
    Xu W; Zhu M; Yuan S; Yu W
    Neurosci Lett; 2016 Nov; 634():52-59. PubMed ID: 27717828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of lipocalin-2-chemokine axis in the development of neuropathic pain following peripheral nerve injury.
    Jeon S; Jha MK; Ock J; Seo J; Jin M; Cho H; Lee WH; Suk K
    J Biol Chem; 2013 Aug; 288(33):24116-27. PubMed ID: 23836894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats.
    Kwiatkowski K; Piotrowska A; Rojewska E; Makuch W; Jurga A; Slusarczyk J; Trojan E; Basta-Kaim A; Mika J
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():68-78. PubMed ID: 26190414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR4 antagonist (C021) influences the level of nociceptive factors and enhances the analgesic potency of morphine in a rat model of neuropathic pain.
    Bogacka J; Popiolek-Barczyk K; Pawlik K; Ciechanowska A; Makuch W; Rojewska E; Dobrogowski J; Przeklasa-Muszynska A; Mika J
    Eur J Pharmacol; 2020 Aug; 880():173166. PubMed ID: 32407723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological blockade of CXCR3 by (±)-NBI-74330 reduces neuropathic pain and enhances opioid effectiveness - Evidence from in vivo and in vitro studies.
    Piotrowska A; Rojewska E; Pawlik K; Kreiner G; Ciechanowska A; Makuch W; Zychowska M; Mika J
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3418-3437. PubMed ID: 30076959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the analgesic properties of the XCL1/XCR1 and XCL1/ITGA9 axes modulation under neuropathic pain conditions - evidence from animal studies.
    Ciechanowska A; Rojewska E; Piotrowska A; Barut J; Pawlik K; Ciapała K; Kreiner G; Mika J
    Front Immunol; 2022; 13():1058204. PubMed ID: 36618360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine contribution to neuropathic pain: respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons.
    Zhang ZJ; Cao DL; Zhang X; Ji RR; Gao YJ
    Pain; 2013 Oct; 154(10):2185-2197. PubMed ID: 23831863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metamizole relieves pain by influencing cytokine levels in dorsal root ganglia in a rat model of neuropathic pain.
    Zajaczkowska R; Kwiatkowski K; Pawlik K; Piotrowska A; Rojewska E; Makuch W; Wordliczek J; Mika J
    Pharmacol Rep; 2020 Oct; 72(5):1310-1322. PubMed ID: 32691345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nitroxyl donor, Angeli's salt, reduces chronic constriction injury-induced neuropathic pain.
    Longhi-Balbinot DT; Rossaneis AC; Pinho-Ribeiro FA; Bertozzi MM; Cunha FQ; Alves-Filho JC; Cunha TM; Peron JP; Miranda KM; Casagrande R; Verri WA
    Chem Biol Interact; 2016 Aug; 256():1-8. PubMed ID: 27287419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SETD7 mediates spinal microgliosis and neuropathic pain in a rat model of peripheral nerve injury.
    Shen Y; Ding Z; Ma S; Ding Z; Zhang Y; Zou Y; Xu F; Yang X; Schäfer MKE; Guo Q; Huang C
    Brain Behav Immun; 2019 Nov; 82():382-395. PubMed ID: 31505256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nrf2/HO-1 signaling pathway participated in the protection of hydrogen sulfide on neuropathic pain in rats.
    Chen H; Xie K; Chen Y; Wang Y; Wang Y; Lian N; Zhang K; Yu Y
    Int Immunopharmacol; 2019 Oct; 75():105746. PubMed ID: 31325725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal P2X(7) receptor mediates microglia activation-induced neuropathic pain in the sciatic nerve injury rat model.
    He WJ; Cui J; Du L; Zhao YD; Burnstock G; Zhou HD; Ruan HZ
    Behav Brain Res; 2012 Jan; 226(1):163-70. PubMed ID: 21933684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice.
    Guida F; Lattanzi R; Boccella S; Maftei D; Romano R; Marconi V; Balboni G; Salvadori S; Scafuro MA; de Novellis V; Negri L; Maione S; Luongo L
    Pharmacol Res; 2015 Jan; 91():36-46. PubMed ID: 25434589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal blockage of CXCL1 and its receptor CXCR2 inhibits paclitaxel-induced peripheral neuropathy in mice.
    Manjavachi MN; Passos GF; Trevisan G; Araújo SB; Pontes JP; Fernandes ES; Costa R; Calixto JB
    Neuropharmacology; 2019 Jun; 151():136-143. PubMed ID: 30991054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connexin-43 induces chemokine release from spinal cord astrocytes to maintain late-phase neuropathic pain in mice.
    Chen G; Park CK; Xie RG; Berta T; Nedergaard M; Ji RR
    Brain; 2014 Aug; 137(Pt 8):2193-209. PubMed ID: 24919967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.